7 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 400 mg PO BID ... Systemic antifungals are ... candida #mucosal #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... or been newly diagnosed ... consecutive Pap tests are ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
Clozapine Toxicology
Clozapine is an atypical antipsychotic most often reserved for use in patients who have treatment-resistant
patients who have treatment-resistant ... Most metabolites are ... known to cause rare ... #Toxicology #Toxicity ... #Diagnosis #Pharmacology
Lithium Therapy for Bipolar Disorder 
Toxicity Levels: 
 - Mild (1-1.5 mEq/L) 
 - Moderate (1.6-2.5
maintenance agent for treatment ... If levels are high ... , patients are at ... Bipolar #Disorder #BPD ... #Toxicity #Pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... concentrations are ... Valganciclovir 900 mg PO BID ... Cytomegalovirus #CMV #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
IDSA Recommendations ... vaccination, health-care ... provider diagnosis ... #Zoster #VZV #IDSA ... infections #HIVAIDS #pharmacology
Diagnosis and Management of Achalasia - ACG Guidelines

Who to suspect?
 • Patients presenting with progressive dysphagia
Diagnosis and Management ... • Patients diagnosed ... with GERD who are ... Pneumatic Dilation (PD ... Botulinum toxin • Pharmacologic